Fact CheckerSign in

NCT07323771Completed

Improving Oral Health Knowledge and Habits in People With Diabetes Through a Theory Guided WhatsApp Education Program

The Effectiveness of Educational Intervention Based on Health Belief Model Delivered Via WhatsApp on Oral Health Knowledge and Behaviors of Individuals With Type 2 Diabetes Mellitus; A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 7 Jan 2026

Brief summary (registry, in English)

The goal of this Educational interventional study is to test the usefulness of an educational program delivered through WhatsApp videos in increasing oral health knowledge and habits in people with Diabetes between the age of 18 and 65 years. The main question it aims to answer is: Does a WhatsApp-based educational Program improve oral health knowledge and behaviors in people with diabetes, and is it more effective than education delivered through brochures? Participants in one group will receive educational videos through WhatsApp, while the other group receive a brochure containing oral health information. Researchers will then compare the groups to see if the intervention made a difference. Participants will: * Fill a baseline questionnaire to assess their current knowledge and behaviors. * They then either participate in a one-month educational program delivered through WhatsApp, or receive an educational brochure. * Wait for 1 month after the program to allow for application of knowledge. * Fill a post intervention questionnaire to assess changes in knowledge and behavior.

Status (registry)
Completed
Study type
Interventional
Enrollment
98 (actual)
First submitted
8 Dec 2025
Start date
15 Sept 2025
Primary completion date
30 Nov 2025
Lead sponsor
Dow University of Health Sciences
NCT number
NCT07323771

What you commit to

  • Study type: Interventional
  • Participants enrolled: 98
  • From 15 Sept 2025 to the primary completion date, 30 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Radiotherapy in head and neck region.

Other illness

  • Individuals diagnosed with life-threatening diseases such as advanced cancer, end-stage renal disease, or severe cardiac failure

Other

  • Edentulous
  • Diminished cognitive ability
  • Planning to migrate during the study period.

Who the study is looking for

  • Adults aged 18-65 years with a confirmed diagnosis of T2DM
  • Able to use WhatsApp for the study duration
  • Able to read and write in Urdu

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Institute of Diabetes & Endocrinology
Coordinator of this site? Confirm its status
KarachiPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.